Mid career · publishing since 2007Rising activity
Prostate Cancer Treatment and ResearchEstrogen and related hormone effectsRNA modifications and cancerCancer-related Molecular PathwaysUbiquitin and proteasome pathways
Publications
132
Citations
2,064
Est. group size
~46
Recurring co-author estimate
Active years
20
Publishing since 2007
In context
Among 4,491 mid career Medicine PIs within our index
Citations: 2,064p25 240 · p75 1,552 · cohort median 614
Publications / year (recent): 14.8p25 1.8 · p75 7.2 · cohort median 3.4
Typically publishes in teams of ~15 · 0% small-team papers (≤3 authors) · across 2 venues
Publication cadence
Publications per year over the last 10 years — averaging 14.8/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- Abstract 3936: CDK12 tumor suppressor function and therapeutic targeting in newly developed mouse models of serous ovarian cancer
Cancer Research · 2025
- cohort_primary from Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma
2023
- Data from Genetic Ablation of the Amplified-in-Breast Cancer 1 Inhibits Spontaneous Prostate Cancer Progression in Mice
2023
- Supplementary Figures 1-3 from Genetic Ablation of the Amplified-in-Breast Cancer 1 Inhibits Spontaneous Prostate Cancer Progression in Mice
2023
- Supplementary Figures 1-3 from Genetic Ablation of the Amplified-in-Breast Cancer 1 Inhibits Spontaneous Prostate Cancer Progression in Mice
2023
- Data from Genetic Ablation of the Amplified-in-Breast Cancer 1 Inhibits Spontaneous Prostate Cancer Progression in Mice
2023
- Supplementary Table 1 from NCOA1 Directly Targets <i>M-CSF1</i> Expression to Promote Breast Cancer Metastasis
2023
- Supplementary Methods from NCOA1 Directly Targets <i>M-CSF1</i> Expression to Promote Breast Cancer Metastasis
2023
- Supplementary Figure 3 from NCOA1 Directly Targets <i>M-CSF1</i> Expression to Promote Breast Cancer Metastasis
2023
- Supplementary Figure 1 from NCOA1 Directly Targets <i>M-CSF1</i> Expression to Promote Breast Cancer Metastasis
2023
- Supplementary Figure 4 from NCOA1 Directly Targets <i>M-CSF1</i> Expression to Promote Breast Cancer Metastasis
2023
- Supplementary Figure 2 from NCOA1 Directly Targets <i>M-CSF1</i> Expression to Promote Breast Cancer Metastasis
2023
- Data from Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma
2023
- cohort_primary from Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma
2023
- cohort_meta from Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma
2023
Publishes in
- Cancer Research×30
- Proceedings of the National Academy of Sciences×8
- bioRxiv (Cold Spring Harbor Laboratory)×5
- Cancer Cell×4
- Neoplasia×4
Similar researchers
By research-topic overlap
- Moray J. Campbell
Medicine · The Ohio State University
- Hedieh Jafari
Medicine · The Ohio State University
- Craig J. Burd
Medicine · The Ohio State University
- Diane M. Robins
Medicine · University of Michigan
- Elizabeth W. LaPensee
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile